Editorial
Published: 18 December, 2018 | Volume 2 - Issue 1 | Pages: 038-040
Roux-en-Y Gastric Bypass surgery is superior to medical treatment for short- to medium-term remission of Type 2 diabetes (T2DM) [1]. Recent research indicates that the improvements in insulin sensitivity following bariatric surgery are associated with elevated circulating bile acid concentration and remodeling of gut microbiota [2]. Gut microbiome can be considered as a target of dietary interventions or medicines to prevention/treatment of hyperglycemia in T2DM. Since, the glucose-lowering effects of metformin are mediated by changes in the composition and function of gut microbiota [3,4].
Read Full Article HTML DOI: 10.29328/journal.afns.1001015 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."